Occupational Exposure to Wood Dust and Respiratory Health Status of Sawmill Workers in South-South Nigeria

Autor: Asogun Da, T. F. Ediagbonya, OH Okojie, E. A. Tobin

Publikováno v: Journal of Pollution Effects & Control.

Ill-health from wood dust inhalation results in decreased work output and increased morbidity. Despite the potentially hazardous nature of the work, there has been little attention given to the state of health and safety of the workers in this indust

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::69552608d2b16de50ffbffc4cfc5487f
https://doi.org/10.4172/2375-4397.1000154

Nasopharyngeal Carcinoma Associated with Lassa Fever Virus Infection

Autor: Ayeke Jo, Saiki Bo, FA Ibiam, Agbonifo M, J Kpolugbo, Esezebor E, G Obasikene, Asogun Da, Tobin Ek, Obasikene Cn, Adobamen Proc

Publikováno v: Journal of Health & Medical Informatics. 5

Nasopharyngeal carcinoma (NPC) is a head and neck cancer usually found in the nasopharynx and arising mostly from Fossa Rosenmueller. The aetiopathogenesis has been linked to environmental factors, genetic susceptibility and Epstein–Barr virus infe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7861463a72e691f985a70931165b0794
https://doi.org/10.4172/2157-7420.1000147

Lassa fever research priorities: towards effective medical countermeasures by the end of the decade.

Autor: Moore KA; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA. Electronic address: kamoore@umn.edu., Ostrowsky JT; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Mehr AJ; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Johnson RA; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Ulrich AK; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Moua NM; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA., Fay PC; Infectious Disease Strategic Programme, Wellcome Trust, London, UK., Hart PJ; Infectious Disease Strategic Programme, Wellcome Trust, London, UK., Golding JP; Infectious Disease Strategic Programme, Wellcome Trust, London, UK., Benassi V; World Health Organization, Geneva, Switzerland., Preziosi MP; World Health Organization, Geneva, Switzerland., Adetifa IM; Nigeria Centre for Disease Control & Prevention, Abuja, Nigeria., Akpede GO; Ambrose Alli University, Ekpoma, Nigeria; Institute of Viral and Emergent Pathogens Control and Research (formerly, Institute of Lassa Fever Research and Control), Irrua Specialist Teaching Hospital, Irrua, Nigeria., Ampofo WK; University of Ghana, Accra, Ghana., Asogun DA; Irrua Specialist Teaching Hospital, Irrua, Nigeria., Barrett ADT; Sealy Institute for Vaccine Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Bausch DG; FIND, Geneva, Switzerland; Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., de Coster I; Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium., Emperador DM; FIND, Geneva, Switzerland., Feldmann H; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Fichet-Calvet E; Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany., Formenty PBH; World Health Organization, Geneva, Switzerland., Garry RF; Tulane University, New Orleans, LA, USA; Zalgen Labs, Frederick, MD, USA; Global Viral Network, Baltimore, MD, USA., Grant DS; Kenema Government Hospital, Ministry of Health and Sanitation, Freetown, Sierra Leone; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone., Günther S; Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany., Gupta SB; lnternational AIDS Vaccine Initiative, New York, NY, USA., Jaspard M; The Alliance for International Medical Action, Dakar, Senegal; Saint-Antoine Hospital, Infectious Disease Department, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM Unit 1136 Institut Pierre Louis D'Epidémiologie et de Sante Publique, Paris, France., Mazzola LT; FIND, Geneva, Switzerland., Okogbenin SA; Irrua Specialist Teaching Hospital, Irrua, Nigeria., Roth C; UK Foreign, Commonwealth and Development Office, London, UK., Schmaljohn CS; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, Frederick, Maryland, USA., Osterholm MT; Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Nov; Vol. 24 (11), pp. e696-e706. Date of Electronic Publication: 2024 Jul 01.

Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.

Autor: Kotliar D; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. dkotliar@mgb.org.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA. dkotliar@mgb.org.; Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. dkotliar@mgb.org., Raju S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA., Tabrizi S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Odia I; Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Goba A; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone., Momoh M; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.; Eastern Polytechnic College, Kenema, Sierra Leone., Sandi JD; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone., Nair P; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Phelan E; Prospr at Work Inc., Berlin, Germany., Tariyal R; NextGen Jane, Inc., Oakland, CA, USA., Eromon PE; Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.; African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Nigeria., Mehta S; Department of Critical Care Medicine, University of Maryland Medical Center, Baltimore, MA, USA., Robles-Sikisaka R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Siddle KJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Stremlau M; Equator Labs Incorporated, Washington, DC, USA., Jalloh S; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone., Gire SK; NextGen Jane, Inc., Oakland, CA, USA., Winnicki S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Chak B; Biological Sciences Division, University of Chicago, Chicago, IL, USA., Schaffner SF; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA., Pauthner M; Vir Biotechnology, San Francisco, CA, USA., Karlsson EK; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Genomics and Computational Biology, UMass Chan Medical School, Worcester, MA, USA.; Program in Molecular Medicine, UMass Chan Medical School, Worcester, MA, USA., Chapin SR; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Kennedy SG; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Branco LM; Zalgen Labs, Frederick, MD, USA., Kanneh L; Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone., Vitti JJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Broodie N; New York-Presbyterian Hospital-Columbia and Cornell, New York, NY, USA., Gladden-Young A; Molecular Microbiology, Graduate School of Biomedical Sciences, Tufts University, Boston, MA, USA., Omoniwa O; Malaria Consortium, Abuja, Nigeria., Jiang PP; Google Medical Brain, Mountain View, CA, USA., Yozwiak N; Gene and Cell Therapy Institute, Mass General Brigham, Cambridge, MA, USA., Heuklom S; San Francisco Community Health Center, San Francisco, CA, USA., Moses LM; Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA., Akpede GO; Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.; Department of Medicine, Ambrose Alli University, Ekpoma, Nigeria., Asogun DA; Department of Community Medicine, Ambrose Alli University, Ekpoma, Nigeria., Rubins K; National Aeronautics and Space Administration, Houston, TX, USA., Kales S; The Jackson Laboratory, Bar Harbor, ME, USA., Happi AN; African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Nigeria., Iruolagbe CO; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Dic-Ijiewere M; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Iraoyah K; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Osazuwa OO; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Okonkwo AK; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Kunz S; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., McCormick JB; UTHealth Houston School of Public Health, Brownsville Campus, Brownsville, TX, USA., Khan SH; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone., Honko AN; Boston University School of Medicine, Boston, MA, USA., Lander ES; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA, USA.; Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Oldstone MBA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Hensley L; National Institutes of Health Integrated Research Facility, Frederick, MA, USA., Folarin OA; African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Nigeria.; Department of Biological Sciences, Redeemer's University, Ede, Nigeria., Okogbenin SA; Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Ollila HM; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Tewhey R; The Jackson Laboratory, Bar Harbor, ME, USA., Okokhere PO; Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.; Department of Medicine, Ambrose Alli University, Ekpoma, Nigeria.; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria., Schieffelin JS; Section of Infectious Disease, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA., Andersen KG; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Reilly SK; Department of Genetics, Yale School of Medicine, New Haven, CT, USA., Grant DS; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.; Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone., Garry RF; Tulane University School of Medicine, New Orleans, LA, USA., Barnes KG; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.; Department of Vector Biology and Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK., Happi CT; African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Nigeria. happic@run.edu.ng.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. happic@run.edu.ng.; Department of Biological Sciences, Redeemer's University, Ede, Nigeria. happic@run.edu.ng., Sabeti PC; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. pardis@broadinstitute.org.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. pardis@broadinstitute.org.; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA. pardis@broadinstitute.org.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. pardis@broadinstitute.org.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. pardis@broadinstitute.org.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA. pardis@broadinstitute.org.

Publikováno v: Nature microbiology [Nat Microbiol] 2024 Mar; Vol. 9 (3), pp. 751-762. Date of Electronic Publication: 2024 Feb 07.

Focussed Assessment with Sonography in acute Lassa Fever (FASLa): Development of a point-of-care protocol and description of common ultrasound findings.

Autor: Erameh CO; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria; Department of Internal Medicine, College of Medicine, Ambrose Alli University, Ekpoma, Nigeria., Koch T; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany., Edeawe OI; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Oestereich L; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany., Omansen T; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany., Jochum J; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Adomeh DI; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Ikponmwonsa O; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Aire C; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Pahlmann M; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany., Asogun DA; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria; Department of Pharmacology & Therapeutics, College of Medicine, Ambrose Alli University, Ekpoma, Nigeria., Ogbaini-Emovon E; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Okogbenin SA; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany., Ramharter M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany., Akideno PE; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Kreuels B; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Germany. Electronic address: kreuels@bnitm.de.

Publikováno v: The Journal of infection [J Infect] 2023 Jul; Vol. 87 (1), pp. 27-33. Date of Electronic Publication: 2023 Apr 17.